| Nanomedicine and society. | |
| | |
MedLine Citation:
|
PMID: 19381150 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Nanomedicine is a reality of medical research and clinical practice, and it offers new and promising approaches to fundamental problems in medicine. Most prominent are the early detection of neoplastic disease and the individualized treatment of metastases. These potentially transformational developments require careful scrutiny of the potential impact of nanomedicine on society, so that the community can guide its deployment in keeping with the fundamental tenets of medical ethics. |
| | |
Authors:
|
M Ferrari; M A Philibert; W R Sanhai |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical pharmacology and therapeutics Volume: 85 ISSN: 1532-6535 ISO Abbreviation: Clin. Pharmacol. Ther. Publication Date: 2009 May |
Date Detail:
|
Created Date: 2009-04-21 Completed Date: 2009-05-04 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372741 Medline TA: Clin Pharmacol Ther Country: United States |
Other Details:
|
Languages: eng Pagination: 466-7 Citation Subset: AIM; IM |
Affiliation:
|
Division of Nanomedicine, University of Texas Houston Health Science Center at Houston, Houston, Texas, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Ethics, Medical* Ethics, Research Humans Nanomedicine / ethics*, methods Nanotechnology / ethics*, methods Neoplasms / diagnosis, therapy Research / methods United States |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Studies should be controlled, randomized, and blinded.
Next Document: Combination products regulation at the FDA.